Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that the previously signed binding Term Sheet between Vincerx, Oqory, Inc., and Vivasor, Inc.

Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patient populatio ...

Transaction included redemption of $1.0 billion 10.500% Senior Unsecured Notes MIAMI, Feb. 28, 2025 /PRNewswire/ -- Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: ...

Toro Corp. (NASDAQ: TORO) ("Toro", or the "Company") an international energy transportation services company, announces that its Board of Directors ...

Reference is made to the announcement by Kaldvik AS ("Kaldvik", the "Company") on 20 December 2024 regarding a potential acquisition of certain key assets in the fish ...

Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B (laromestrocel) in Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric disease and orphan-designated indication, has achieved more ...

Mondelez International (Nasdaq: MDLZ) today announced the appointment of Norberto Chaclin as Executive Vice President and Chief Research & Development Officer.

Quisitive Technology Solutions Inc. ("Quisitive" or the "Company") (TSXV: QUIS; OTCQX: QUISF), a premier Microsoft Cloud and AI solutions provider, is pleased ...

CNW/ - Birks Group Inc. (the "Company") (NYSE American LLC: BGI), announced that it received notice from the NYSE American LLC ("NYSE American") ...

Fourth Quarter 2024 Revenues of $1.7 billion EPS of $(5.38); Adjusted EPS* of $(4.22) Cash provided by operations ...

LZ Technology Holdings Limited (NASDAQ: LZMH) ("LZ Technology" or the "Company"), an information technology and advertising company, today announced ...

Saul Centers, Inc. (NYSE: BFS), an equity real estate investment trust ("REIT"), announced operating results for the ...